Correlation Between Candel Therapeutics and Larimar Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Candel Therapeutics and Larimar Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Candel Therapeutics and Larimar Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Candel Therapeutics and Larimar Therapeutics, you can compare the effects of market volatilities on Candel Therapeutics and Larimar Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Candel Therapeutics with a short position of Larimar Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Candel Therapeutics and Larimar Therapeutics.

Diversification Opportunities for Candel Therapeutics and Larimar Therapeutics

0.61
  Correlation Coefficient

Poor diversification

The 3 months correlation between Candel and Larimar is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Candel Therapeutics and Larimar Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Larimar Therapeutics and Candel Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Candel Therapeutics are associated (or correlated) with Larimar Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Larimar Therapeutics has no effect on the direction of Candel Therapeutics i.e., Candel Therapeutics and Larimar Therapeutics go up and down completely randomly.

Pair Corralation between Candel Therapeutics and Larimar Therapeutics

Given the investment horizon of 90 days Candel Therapeutics is expected to under-perform the Larimar Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Candel Therapeutics is 1.78 times less risky than Larimar Therapeutics. The stock trades about -0.06 of its potential returns per unit of risk. The Larimar Therapeutics is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  371.00  in Larimar Therapeutics on September 1, 2025 and sell it today you would lose (17.00) from holding Larimar Therapeutics or give up 4.58% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Candel Therapeutics  vs.  Larimar Therapeutics

 Performance 
       Timeline  
Candel Therapeutics 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Candel Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's fundamental indicators remain quite persistent which may send shares a bit higher in December 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Larimar Therapeutics 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Larimar Therapeutics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Even with relatively inconsistent primary indicators, Larimar Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

Candel Therapeutics and Larimar Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Candel Therapeutics and Larimar Therapeutics

The main advantage of trading using opposite Candel Therapeutics and Larimar Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Candel Therapeutics position performs unexpectedly, Larimar Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Larimar Therapeutics will offset losses from the drop in Larimar Therapeutics' long position.
The idea behind Candel Therapeutics and Larimar Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Complementary Tools

Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings